Literature DB >> 25796578

Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.

Nadine Berndt1,2, Catherine Bolman3, Lilian Lechner3, Wendy Max4, Aart Mudde3, Hein de Vries5, Silvia Evers6,7.   

Abstract

OBJECTIVE: This study examined the cost-effectiveness and cost-utility of two smoking cessation counseling interventions differing in their modality for patients diagnosed with coronary heart disease from a societal perspective.
METHODS: In a randomized controlled trial conducted in Dutch hospital wards, cardiac patients who smoked prior to admission were allocated to usual care (n = 245), telephone counseling (n = 223) or face-to-face counseling (n = 157). The counseling interventions lasted for 3 months and were complemented by nicotine patches. Baseline histories were obtained, and interviews took place 6 months after hospitalization to assess self-reported smoking status and quality adjusted life years (QALYs). Incremental cost-effectiveness ratios per quitter and cost-utility ratios per QALY were calculated and presented in acceptability curves. Uncertainty was accounted for by sensitivity analysis.
RESULTS: Using continued abstinence as the outcome measure showed that telephone counseling had the highest probability of being cost-effective. Face-to-to-face counseling was also more cost-effective than usual care. No significant improvements and differences in QALYs between the three conditions were found. Varying costs and effect estimations revealed that the results of the primary analyses were robust.
CONCLUSIONS: Assuming a willingness-to-pay of €20,000 per abstinent patient, telephone counseling would be a highly cost-effective smoking cessation intervention assisting cardiac patients to quit. However, the lack of consensus concerning the willingness-to-pay per quitter impedes drawing firm conclusions. Moreover, studies with extended follow-up periods are needed to capture late relapses and possible differences in QALYs.

Entities:  

Keywords:  Coronary heart disease; Economic evaluation; Face-to-face counseling; Quality of life; Smoking cessation; Telephone counseling

Mesh:

Year:  2015        PMID: 25796578     DOI: 10.1007/s10198-015-0677-x

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  66 in total

1.  Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysis.

Authors:  Cornelis Boersma; Adriaan Broere; Maarten J Postma
Journal:  Value Health       Date:  2010 Sep-Oct       Impact factor: 5.725

2.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

Authors:  Andrea Manca; Neil Hawkins; Mark J Sculpher
Journal:  Health Econ       Date:  2005-05       Impact factor: 3.046

Review 3.  Individual behavioural counselling for smoking cessation.

Authors:  T Lancaster; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data.

Authors:  Andrea Burton; Lucinda Jane Billingham; Stirling Bryan
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

Review 5.  Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? Meta-analysis of interventions.

Authors:  M Huttunen-Lenz; F Song; F Poland
Journal:  Br J Health Psychol       Date:  2010-01-16

6.  Smoking cessation may not improve quality of life in atherosclerotic patients.

Authors:  Louise C W Wiggers; Frans J Oort; Ron J G Peters; Dink A Legemate; Hanneke C J M de Haes; Ellen M A Smets
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

Review 7.  Nursing interventions in tobacco-dependent patients with cardiovascular diseases.

Authors:  Kawkab Shishani; Min Sohn; Ayako Okada; Erika Sivarajan Froelicher
Journal:  Annu Rev Nurs Res       Date:  2009

8.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

9.  A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation.

Authors:  Catherine Bolman; Hein de Vries; Gerard van Breukelen
Journal:  Prev Med       Date:  2002-08       Impact factor: 4.018

10.  Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial.

Authors:  Patricia M Smith; Ellen Burgess
Journal:  CMAJ       Date:  2009-06-23       Impact factor: 8.262

View more
  6 in total

1.  Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review.

Authors:  Donghoon Lee; Ye-Rin Lee; In-Hwan Oh
Journal:  Eur J Health Econ       Date:  2019-08-26

Review 2.  Smoking cessation and the cardiovascular patient.

Authors:  Judith J Prochaska; Neal L Benowitz
Journal:  Curr Opin Cardiol       Date:  2015-09       Impact factor: 2.161

3.  A referral aid for smoking cessation interventions in primary care: study protocol for a randomized controlled trial.

Authors:  Daniëlle N Zijlstra; Jean W M Muris; Catherine Bolman; J Mathis Elling; Vera E R A Knapen; Hein de Vries
Journal:  Prim Health Care Res Dev       Date:  2021-05-26       Impact factor: 1.458

4.  Telephone counselling for smoking cessation.

Authors:  William Matkin; José M Ordóñez-Mena; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-05-02

5.  Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease.

Authors:  Thaís Garcia; Sílvia Aline Dos Santos Andrade; Angélica Teresa Biral; André Luiz Bertani; Laura Miranda de Oliveira Caram; Talita Jacon Cezare; Irma Godoy; Suzana Erico Tanni
Journal:  J Bras Pneumol       Date:  2018 Jan-Feb       Impact factor: 2.624

6.  How to persuade more primary care professionals to adopt a valued smoking cessation referral aid: a cross-sectional study of facilitators and barriers.

Authors:  Daniëlle N Zijlstra; Catherine Aw Bolman; Jean Wm Muris; Hein de Vries
Journal:  BMC Prim Care       Date:  2022-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.